PCRX
Pacira BioSciences·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
Latest data update time: Updated on 2026-02-07
4.36 / 10Overall Score
NeturalInvestment Rating
4.36 / 10Overall Score
NeturalInvestment Rating
Should I Buy PCRX Now?
- Based on a composite score of 4.36/10, we rate PCRX as a Netural. Our analysis breaks down into 2.59/10 for Fundamentals, 3.38/10 for Technicals, and 5.73/10 for Sentiment, indicating the stock is likely to consolidate sideways.
What is the current technical signals for PCRX?
Is PCRX fundamentally strong?
What is the market sentiment for PCRX?
Should I Buy PCRX Now?
- Based on a composite score of 4.36/10, we rate PCRX as a Netural. Our analysis breaks down into 2.59/10 for Fundamentals, 3.38/10 for Technicals, and 5.73/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is PCRX fundamentally strong?
What is the current technical signals for PCRX?
What is the market sentiment for PCRX?
